High seroconversion rate to trivalent influenza vaccine during ustekinumab treatment in Crohn's disease: results from a prospective cohort study
Rogier Goetgebuer 1
Laura Doornekamp 1
Gwenny M. Fuhler 1
Maikel P. Peppelenbosch 1
C. Janneke van der Woude 2
Eric C.M. van Gorp
Annemarie C. De Vries
1 Erasmus MC, University Medical Center Rotterdam,Rotterdam,Netherlands
2 Erasmus MC, University Medical Center Rotterdam,Rotte
Session
IBD: New drugs, new risks
Conference
UEG Week 2019
Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing